Arvinas, Inc. (ARVN)
11.13
+0.13
(+1.18%)
USD |
NASDAQ |
Apr 17, 12:33
Arvinas Research and Development Expense (Quarterly) : 59.80M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 3.133B |
| EyePoint Plc | 59.21M |
| Apellis Pharmaceuticals, Inc. | 74.23M |
| Elanco Animal Health, Inc. | 93.00M |
| Gossamer Bio, Inc. | 48.93M |